Official UK procurement notice
SECUKINUMAB (COSENTYX) 150 mg and 300mg Pre-filled Pen and Syringes via homecare
Authority: Northern Health and Social Care Trust (Central government)
What is being bought
Published requirement descriptionContract for supply of SECUKINUMAB (COSENTYX) 150 mg and 300mg Pre-filled Pen and Syringes via homecare for a period of up to 3 years
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 17 Aug 2026, 14:41 BST
- Last source update
- 10 Sept 2026, 12:57 BST
- Authority reference
DAC186/0726PM- FTS notice number
2026/S 000-085866- Latest notice
- Contract details notice (UK7)
- Delivery area
- Official registry OCID
ocds-h6vhtk-06e5b6Find a Tender
- Why no open competition
- Single Suppliers Technical Reasons
- Published justification
Single supplier - technical reasons
Section 41 schedule 5(6) of the PA2023 permits a direct award if the following conditions are met in relation to the public contract:
(a)due to an absence of competition for technical reasons, only a particular supplier can supply the goods, services or works required, and
(b)there are no reasonable alternatives to those goods, services or works.
The Northern Health and Social Care Trust requires the purchase of Secukinumab which is subject to patent protection / Sole MA Holder and consequently no reasonable alternative of substitute exists.
These essential medicines are required from this supplier to ensure continuity of patient care, specifically for homecare support. The absence of competition is not the artificial narrowing of the parameters of the procurement.
Notice history
4 events · 3 releases on Find a Tender · since 17 Aug 2026- Transparency notice published17 Aug 2026, 14:41 BSTUK5
- Contract award notice published17 Aug 2026, 14:48 BSTUK6
- Contract signature expected28 Aug 2026, 23:59 BSTscheduled
- Contract details notice published10 Sept 2026, 12:57 BSTUK7
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Sciensus Pharma Services LtdSECUKINUMAB (COSENTYX) via Homecare1 Sept 2026 – 31 Aug 2029 | £4,000,000 | 17 Aug 2026 | Awarded |
Contracts
Contract 1 · Sciensus Pharma Services Ltd
- Signed
- 10 Sept 2026
- Value
- £4,000,000
- Period
- 10 Sept 2026 – 31 Aug 2029
- Status
- active
No agreed KPIs: Not applicable as contract value is less than 5 million
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- SCIENSUS PHARMA SERVICES LIMITEDAwarded supplier
Official documents & specifications (3)
Official links; attachments are not copiedNotices published for this procedure
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Transparency notice Transparency notice on Find a Tender